In a murine model of arterial hypertension, liraglutide, a GLP-1RA, normalizes blood pressure, cardiac hypertrophy, vascular fibrosis, endothelial dysfunction, oxidative stress and vascular inflammation through the GLP-1/GLP-1R axis (figure 3) [211]. The gene discussed is GLP1R; the disease is endothelial dysfunction.